Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

B Wang, L Wu, J Chen, L Dong, C Chen… - Signal transduction and …, 2021 - nature.com
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology,
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …

Arachidonic acid metabolites in cardiovascular and metabolic diseases

T Sonnweber, A Pizzini, M Nairz, G Weiss… - International journal of …, 2018 - mdpi.com
Lipid and immune pathways are crucial in the pathophysiology of metabolic and
cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to …

Effects of arachidonic acid metabolites on cardiovascular health and disease

Y Zhou, H Khan, J Xiao, WS Cheang - International journal of molecular …, 2021 - mdpi.com
Arachidonic acid (AA) is an essential fatty acid that is released by phospholipids in cell
membranes and metabolized by cyclooxygenase (COX), cytochrome P450 (CYP) enzymes …

Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease

JZ Haeggstrom, CD Funk - Chemical reviews, 2011 - ACS Publications
Metabolism of arachidonic acid leads to several families of lipid mediators, including
prostaglandins, thromboxane, leukotrienes, and lipoxins, along two major metabolic …

Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK

X Wang, XL Wang, HL Chen, D Wu, JX Chen… - Biochemical …, 2014 - Elsevier
Doxorubicin (DOX) is a wide spectrum antitumor drug, but its clinical application is limited by
the cardiotoxicity. Ghrelin, a multi-functional peptide hormone with metabolic regulation in …

SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms

XX Wang, XL Wang, M Tong, L Gan, H Chen… - Basic research in …, 2016 - Springer
SIRT6, a member of the NAD (+)-dependent class III deacetylase sirtuin family, has been
revealed to play important roles in promoting cellular resistance against oxidative stress …

Montelukast and acute coronary syndrome: the endowed drug

BM Alomair, HM Al-Kuraishy, AI Al-Gareeb… - Pharmaceuticals, 2022 - mdpi.com
Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …

The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease

D Poeckel, CD Funk - Cardiovascular research, 2010 - academic.oup.com
Abstract Leukotrienes (LTs) derived from 5-lipoxygenase (5-LO) activity are most widely
known for their actions during acute inflammation and asthma. 5-LO/LT pathway …

Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein–coupled receptor, GPR99

LG Bankova, J Lai, E Yoshimoto… - Proceedings of the …, 2016 - National Acad Sciences
Cysteinyl leukotrienes (cysLTs), leukotriene C4 (LTC4), LTD4, and LTE4 are
proinflammatory lipid mediators with pathobiologic function in asthma. LTE4, the stable …

The leukotrienes: immune-modulating lipid mediators of disease

A Di Gennaro, JZ Haeggström - Advances in immunology, 2012 - Elsevier
The leukotrienes are important lipid mediators with immune modulatory and proinflammatory
properties. Classical bioactions of leukotrienes include chemotaxis, endothelial adherence …